Avastin-Related Eye Infections Could Bring FDA Pressure On Compounding Pharmacies
This article was originally published in The Pink Sheet Daily
Executive Summary
An FDA alert about a cluster of Streptococcus endophthalmitis infections in Florida suggests concerns about aseptic conditions in pharmacies that repackage Avastin for off-label intravitreal use.